Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1037-1046

  Lewis, Gary F ^a,b   Carpentier, André ^a   Bilinski, Debra ^a   Giacca, Adria ^a   Vranic, Mladen ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCOSE; INSULIN; NORADRENALIN;

ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESPONSE; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PANCREAS SECRETION; PRIORITY JOURNAL;

EID: 0032987694     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.1037     Document Type: Article

References (51)

1. Cryer PE, Fisher JN, Shamoon H. 1994 Hypoglycemia [Review], Diabetes Care. 17:734-755.
2. Pramming S, Thorsteinsson B, Bendtson I, Binder C. 1991 Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabetic Med. 8:217-222.
3. Diabetes Control and Complications Trial Research Group. 1987 Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care. 10:1-19.
4. Diabetes Control and Complications Trial Research Group. 1991 Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 90:450-459.
5. Davis SN, Cherrington AD. 1993 The hormonal and metabolic responses to prolonged hypoglycemia [Review]. J Lab Clin Med. 121:21-31.
6. Hevener AL, Bergman RN, Donovan CM. 1997 Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes. 46:1521-1525.
7. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. 1994 Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci USA. 91:2863-2867.
8. Donovan CM, Cane P, Bergman RN. 1991 Search for the hypoglycemia receptor using the local irrigation approach [Review]. Adv Exp Med Biol. 291:185-196.
9. Donovan CM, Halter JB, Bergman RN. 1991 Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes. 40:155-158.
10. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B. 1994 A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide vs. insulin infusion. J Clin Endocrinol Metab. 79:66-70.
11. Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G. 1994 VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physiol 267:E566-E672.
12. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A. 1996 Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 45:454-462.
13. Lewis GF, Vranic M, Giacca A. 1997 Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol 272:E371-E378.
14. Lewis GF, Vranic M, Harley P, Giacca A. 1997 Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes. 46:1111-1119.
15. 3H]glucose. Am J Physiol 258:E228-E233.
16. Finegood DT, Bergman RN, Vranic M. 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 36:914-924.
17. Finegood DT, Bergman RN, Vranic M. 1988 Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes. 37:1025-1034.
18. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 41:368-377.
19. Finegood DT, Bergman RN. 1983 Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol. 244:E472-E479.
20. Bradley DC, Steil GM, Bergman RN. 1993 Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol. 264:E902-E911.
21. Faber OK, Binder C, Markussen J, et al. 1978 Characterization of seven C-peptide antisera. Diabetes. 27(Suppl 1):170-177.
22. Peuler JD, Johnson GA. 1977 Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 21:625-636.
23. Lloyd B, Burrin J, Smythe P, Alberti KG. 1978 Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem. 24:1724-1729.
24. Diamond MP, Hallarman L, Starick-Zych K, et al. 1991 Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. J Clin Endocrinol Metab. 72:1388-1390.
25. Liu D, Moberg E, Kollind M, Lins PE, Adamson U. 1991 A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. J Clin Endocrinol Metab. 73:1123-1128.
26. Liu DT, Adamson UC, Lins PE, Kollind ME, Moberg EA, Andreasson K. 1992 Inhibitory effect of circulating insulin on glucagon secretion during hypoglycemia in type I diabetic patients. Diabetes Care. 15:59-65.
27. Moriarty KT, Simpson EJ, Mullinger RN, MacDonald IA, Tattersall RB. 1993 Antecedent insulin level and pattern of induction of acute hypoglycaemia do not affect subsequent counterreguiatory responses in healthy subjects. Clin Sci. 85:543-548.
28. Bolli G, De Feo P, Perriello G, et al. 1984 Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the β cell and arterial hyperinsulinemia. J Clin Invest. 73:917-922.
29. Mellman MJ, Davis MR, Shamoon H. 1992 Effect of physiological hyperinsulinemia on counterreguiatory hormone responses during hypoglycemia in humans. J Clin Endocrinol Metab. 75:1293-1297.
30. Davis SN, Dobbins R, Colbum C, Tarumi C, Jacobs J, Neal D, Cherrington AD. 1993 Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs. Am J Physiol. 264:E748-E755.
31. Davis SN, Dobbins R, Tarumi C, Colburn C, Neal D, Cherrington AD. 1992 Effects of differing insulin levels on response to equivalent hypoglycemia in conscious dogs. Am J Physiol. 263:E688-E695.
32. Davis SN, Goldstein RE, Jacobs J, Price L, Wolfe R, Cherrington AD. 1993 The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes. 42:263-272.
33. Davis SN, Cherrington AD, Goldstein RE, Jacobs J, Price L. 1993 Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females. Am J Physiol 265:E680-E689.
34. Davis SN, Goldstein RE, Price L, Jacobs J, Cherrington AD. 1993 The effects of insulin on the counterregulatory response to equivalent hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 77:1300-1307.
35. Samols E, Stagner JI. 1991 Intraislet and islet-acinar portal systems and their significance. In: Samols E, ed. The endocrine pancreas. New York: Raven Press; 93-124.
36. Bonner-Weir, S. 1991 Anotomy of the islet of Langerhans. In: Samols E, ed. The endocrine pancreas. New York: Raven Press; 15-27.
37. Stagner JI, Samols E. 1986 Retrograde perfusion as a model for testing the relative effects of glucose vs. insulin on the A cell. J Clin Invest. 77:1034-1037.
38. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. 1984 Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 74:2296-2299.
39. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Vranic M. 1992 Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest. 90:1769-1777.
40. Peacey SR, Rostami-Hodjegan A, George E, Tucker GT, Heller SR. 1997 The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans. J Clin Endocrinol Metab. 82:1458-1461.
41. Landstedt-Hallin L, Adamson U, Lins PE. 1998 Effect of oral glibenclamide on the glucagon and adrenaline responses to hypoglycemia in insulin-treated patients with type 2 diabetes. Diabetes. 47(Suppl 1):A37.
42. Saudek CD, Selam JL, Pitt HA, et al. 1989 A preliminary trial of the programmable implantahle medication system for insulin delivery. N Engl J Med. 321:574-579.
43. Selam JL, Micossi P, Dunn FL, Nathan DM. 1992 Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care. 15:877-885.
44. Shi ZQ, Wan C, Matsuhisa M, El-Bahrani B, Rodgers C, Giacca A. 1995 Intraperitoneal, in contrast to subcutaneous, insulin markedly improves the responses of glucagon and glucose production to hypoglycemia in diabetic rats. Diabetes. 44(Suppl 1):93A.
45. Shi ZQ, Rastogi KS, Lekas M, Efendic S, Drucker DJ, Vranic M. 1996 Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats. Endocrinology. 137:3193-3199.
46. Scanlon MF, Issa BG, Dieguez C. 1996 Regulation of growth hormone secretion [Review]. Horm Res. 46:149-154.
47. Casanueva FF, Villanueva L, Dieguez C, et al. 1987 Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 65:634-642.
48. Imaki T, Shibasaki T, Masuda A, et al. 1986 The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology. 118:2390-2394.
49. Vance ML. 1993 Metabolic status and growth hormone secretion in man [Review]. J Pediatr Endocrinol. 6:267-272.
50. Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM. 1976 The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest. 58:7-15.
51. Davis SN, Shavers C, Collins L, Cherrington AD, Price L, Hedstrom C. 1994 Effects of physiological hyperinsulinemia on counterregulatory response to prolonged hypoglycemia in normal humans. Am J Physiol 267:E402-E410.